JP2022551672A5 - - Google Patents
Info
- Publication number
- JP2022551672A5 JP2022551672A5 JP2022522322A JP2022522322A JP2022551672A5 JP 2022551672 A5 JP2022551672 A5 JP 2022551672A5 JP 2022522322 A JP2022522322 A JP 2022522322A JP 2022522322 A JP2022522322 A JP 2022522322A JP 2022551672 A5 JP2022551672 A5 JP 2022551672A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- breast cancer
- composition according
- effective amount
- mammary gland
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962914833P | 2019-10-14 | 2019-10-14 | |
| US62/914,833 | 2019-10-14 | ||
| PCT/US2020/055219 WO2021076444A1 (en) | 2019-10-14 | 2020-10-12 | Methods for treating breast cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551672A JP2022551672A (ja) | 2022-12-12 |
| JP2022551672A5 true JP2022551672A5 (cg-RX-API-DMAC10.html) | 2023-09-20 |
Family
ID=75538857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522322A Pending JP2022551672A (ja) | 2019-10-14 | 2020-10-12 | 乳癌治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12582628B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4045009A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022551672A (cg-RX-API-DMAC10.html) |
| CN (1) | CN114555053B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020366300B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021076444A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025501657A (ja) * | 2022-01-10 | 2025-01-22 | オラテック セラピューティクス， インコーポレイティド | 膵臓がんを治療するための方法 |
| EP4487122A4 (en) * | 2022-03-02 | 2026-03-11 | Olatec Therapeutics Inc | TREATMENT METHODS FOR PATIENTS WITH SOLID CANCER AND CLONAL HEMATOPOIESIS OF UNDETERMINED POTENTIAL |
| WO2026035767A1 (en) * | 2024-08-06 | 2026-02-12 | Olatec Therapeutics, Inc. | Methods for treating melanoma metastasis to liver and lungs |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013006708A (es) | 2010-12-15 | 2013-09-13 | Olatec Ind Llc | Composicion de 3-metanosulfonilpropionitrilo para el tratamiento de la inflamacion y el dolor. |
| CN104768553A (zh) * | 2012-11-02 | 2015-07-08 | 默克专利股份公司 | 用于治疗肝细胞癌(hcc)的6-氧代-1,6-二氢-哒嗪衍生物 |
| UA122479C2 (uk) * | 2014-01-24 | 2020-11-25 | Дана-Фарбер Кенсер Інстітьют, Інк. | Виділена молекула антитіла, яка зв’язується з людським білком програмованої смерті-1 (pd-1) |
| ES2970485T3 (es) * | 2017-01-06 | 2024-05-29 | Olatec Therapeutics Llc | Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares |
| EP3589370A4 (en) * | 2017-01-06 | 2020-11-18 | Olatec Therapeutics LLC | MULTIPLE SCLEROSIS TREATMENT METHOD |
| AU2018313164A1 (en) * | 2017-08-11 | 2020-03-19 | Olatec Therapeutics Llc | Method for treating Schnitzler's syndrome |
| WO2019152627A1 (en) * | 2018-01-31 | 2019-08-08 | Olatec Therapeutics Llc | Method for preventing or treating alzheimer's disease |
| JP7229565B2 (ja) * | 2018-03-21 | 2023-02-28 | オラテック セラピューティクス リミティド ライアビリティ カンパニー | メラノーマを治療するための方法 |
-
2020
- 2020-10-12 EP EP20877745.8A patent/EP4045009A4/en active Pending
- 2020-10-12 WO PCT/US2020/055219 patent/WO2021076444A1/en not_active Ceased
- 2020-10-12 JP JP2022522322A patent/JP2022551672A/ja active Pending
- 2020-10-12 AU AU2020366300A patent/AU2020366300B2/en active Active
- 2020-10-12 CN CN202080071066.3A patent/CN114555053B/zh active Active
-
2022
- 2022-04-13 US US17/659,121 patent/US12582628B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McCormack et al. | The changing role of surgery for pulmonary metastases | |
| JP2023512039A5 (cg-RX-API-DMAC10.html) | ||
| IL277434B2 (en) | shp2 phosphatase inhibitors and methods of using them | |
| JP2022153392A5 (cg-RX-API-DMAC10.html) | ||
| JP2022121594A5 (cg-RX-API-DMAC10.html) | ||
| JP2024156779A5 (cg-RX-API-DMAC10.html) | ||
| Wrightson et al. | Primary squamous cell carcinoma of the breast presenting as a breast abscess | |
| JP2023553533A5 (cg-RX-API-DMAC10.html) | ||
| WO2017177962A1 (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| JP2022547331A5 (cg-RX-API-DMAC10.html) | ||
| RU2017146346A (ru) | Комбинированная терапия pac-1 | |
| Mascarenhas et al. | Recurrent metastatic renal cell carcinoma presenting as a bleeding gastric ulcer after a complete response to high-dose interleukin-2 treatment | |
| Bolwell et al. | Peutz‐Jeghers syndrome with pseudoinvasion of hamartomatous polyps and multiple epithelial neoplasms | |
| CN110494131A (zh) | 精胺及其衍生物在制备抗肿瘤药物中的应用 | |
| JP2021518374A5 (cg-RX-API-DMAC10.html) | ||
| Mohanty et al. | Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature | |
| JP2024510975A5 (cg-RX-API-DMAC10.html) | ||
| Hørding et al. | Stage I endometrial carcinoma: a review of 140 patients primarily treated by surgery only | |
| JP2023515687A5 (cg-RX-API-DMAC10.html) | ||
| Yarom et al. | Sacrococcygeal chordoma with unusual metastases | |
| JP2020514345A5 (cg-RX-API-DMAC10.html) | ||
| JP2024520307A5 (cg-RX-API-DMAC10.html) | ||
| Portales et al. | Breast metastasis from cutaneous melanoma: beyond the infiltrating ductal carcinoma | |
| Shintani et al. | Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient | |
| JP2025508502A5 (cg-RX-API-DMAC10.html) |